<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Supp/Beta_Glucan.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:34:07 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="2805007">
<meta name="Category" content="Supp">
<meta name="Article" content="Beta_Glucan">
<title>Beta Glucano-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Beta Glucano</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Beta_Glucan.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Czop JK. The role of beta-glucan receptors on blood and tissue leukocytes in
phagocytosis and metabolic activation. <em>Pathol Immunopathol Res</em> 1986;5:286-96.</li>

<li class="Ref">Wakshull E, Brunke-Reese D, Lindermuth J, et al. PGG-glucan, a soluble
beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates
an NF-kappa B-like factor in human PMN: evidence for a glycosphingolipid beta-(1,3)-glucan
receptor. <em>Immunopharmacology</em> 1999;41:89-107.</li>

<li class="Ref">Czop JK, Kay J. Isolation and characterization of beta-glucan receptors on
human mononuclear phagocytes. <em>J Exp Med</em> 1991;173:1511-20.</li>

<li class="Ref">Czop JK, Puglisi AV, Miorandi DZ, Austen KF. Perturbation of beta-glucan
receptors on human neutrophils initiates phagocytosis and leukotriene B4 production. <em>J
Immunol</em> 1988;141:3170-6.</li>

<li class="Ref">Estrada A, Yun CH, Van Kessel A, et al. Immunomodulatory activities of oat
beta-glucan in vitro and in vivo. <em>Microbiol Immunol</em> 1997;41:991-8.</li>

<li class="Ref">Ooi VE, Liu F. Immunomodulation and anti-cancer activity of
polysaccharide-protein complexes. <em>Curr Med Chem</em> 2000;7:715-29 [review].</li>

<li class="Ref">Ross GD, Vetvicka V, Yan J, et al. Therapeutic intervention with complement
and beta-glucan in cancer. <em>Immunopharmacology</em> 1999;42:61-74.</li>

<li class="Ref">Di Renzo L, Yefenof E, Klein E. The function of human NK cells is enhanced by
beta-glucan, a ligand of CR3 (CD11b/CD18). <em>Eur J Immunol</em> 1991 Jul;21:1755-8.</li>

<li class="Ref">Bell S, Goldman VM, Bistrian BR, et al. Effect of beta-glucan from oats and
yeast on serum lipids. <em>Crit Rev Food Sci Nutr</em> 1999;39:189-202 [review].</li>

<li class="Ref">Bell S, Goldman VM, Bistrian BR, et al. Effect of beta-glucan from oats and
yeast on serum lipids. <em>Crit Rev Food Sci Nutr</em> 1999;39:189-202 [review].</li>

<li class="Ref">Behall KM, Scholfield DJ, Hallfrisch J. Effect of beta-glucan level in oat
fiber extracts on blood lipids in men and women. <em>J Am Coll Nutr</em> 1997;16:46-51.</li>

<li class="Ref">Braaten JT, Wood PJ, Scott FW, et al. Oat beta-glucan reduces blood
cholesterol concentration in hypercholesterolemic subjects. <em>Eur J Clin Nutr</em>
1994;48:465-74.</li>

<li class="Ref">Davidson MH, Dugan LD, Burns JH, et al. The hypocholesterolemic effects of
beta-glucan in oatmeal and oat bran. A dose-controlled study. <em>JAMA</em>
1991;265:1833-9.</li>

<li class="Ref">Wood PJ. Physicochemical properties and physiological effects of the
(1----3)(1----4)-beta-D-glucan from oats. <em>Adv Exp Med Biol</em> 1990;270:119-27.</li>

<li class="Ref">Uusitupa MI, Miettinen TA, Sarkkinen ES, et al. Lathosterol and other
non-cholesterol sterols during treatment of hypercholesterolaemia with beta-glucan-rich oat
bran. <em>Eur J Clin Nutr</em> 1997;51:607-11.</li>

<li class="Ref">Lia A, Hallmans G, Sandberg AS, et al. Oat beta-glucan increases bile acid
excretion and a fiber-rich barley fraction increases cholesterol excretion in ileostomy
subjects. <em>Am J Clin Nutr</em> 1995;62:1245-51.</li>

<li class="Ref">Bell S, Goldman VM, Bistrian BR, et al. Effect of beta-glucan from oats and
yeast on serum lipids. <em>Crit Rev Food Sci Nutr</em> 1999;39:189-202 [review].</li>

<li class="Ref">Nicolosi R, Bell SJ, Bistrian BR, et al. Plasma lipid changes after
supplementation with beta-glucan fiber from yeast. <em>Am J Clin Nutr</em>
1999;70:208-12.</li>

<li class="Ref">Behall KM, Scholfield DJ, Hallfrisch J. Effect of beta-glucan level in oat
fiber extracts on blood lipids in men and women. <em>J Am Coll Nutr</em> 1997;16:46-51.</li>

<li class="Ref">Braaten JT, Wood PJ, Scott FW, et al. Oat beta-glucan reduces blood
cholesterol concentration in hypercholesterolemic subjects. <em>Eur J Clin Nutr</em>
1994;48:465-74.</li>

<li class="Ref">Uusitupa MI, Ruuskanen E, Makinen E, et al. A controlled study on the effect
of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to
apolipoprotein E phenotype. <em>J Am Coll Nutr</em> 1992;11:651-9.</li>

<li class="Ref">Braaten JT, Scott FW, Wood PJ, et al. High beta-glucan oat bran and oat gum
reduce postprandial blood glucose and insulin in subjects with and without type 2 diabetes.
<em>Diabet Med</em> 1994;11:312-8.</li>

<li class="Ref">Wood PJ. Physicochemical properties and physiological effects of the
(1----3)(1----4)-beta-D-glucan from oats. <em>Adv Exp Med Biol</em> 1990;270:119-27.</li>

<li class="Ref">Bourdon I, Yokoyama W, Davis P, et al. Postprandial lipid, glucose, insulin,
and cholecystokinin responses in men fed barley pasta enriched with beta-glucan. <em>Am J Clin
Nutr</em> 1999;69:55-63.</li>

<li class="Ref">Pick ME, Hawrysh ZJ, Gee MI. Oat bran concentrate bread products improve
long-term control of diabetes: a pilot study. <em>J Am Diet Assoc</em> 1996;96:1254-61.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Supp/Beta_Glucan.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:34:07 GMT -->
</html>

